Amphastar Pharmaceuticals Research and Development Expenses 2012-2025 | AMPH
Amphastar Pharmaceuticals research and development expenses from 2012 to 2025. Research and development expenses can be defined as an expense arising from studies and product development processes.
Amphastar Pharmaceuticals Annual Research and Development Expenses
(Millions of US $) |
| 2024 |
$74 |
| 2023 |
$74 |
| 2022 |
$75 |
| 2021 |
$61 |
| 2020 |
$67 |
| 2019 |
$69 |
| 2018 |
$58 |
| 2017 |
$44 |
| 2016 |
$42 |
| 2015 |
$37 |
| 2014 |
$29 |
| 2013 |
$33 |
| 2012 |
$31 |
| 2011 |
$31 |
| 2009 |
$0 |
Amphastar Pharmaceuticals Quarterly Research and Development Expenses
(Millions of US $) |
| 2025-03-31 |
$20 |
| 2024-12-31 |
$18 |
| 2024-09-30 |
$21 |
| 2024-06-30 |
$18 |
| 2024-03-31 |
$17 |
| 2023-12-31 |
$20 |
| 2023-09-30 |
$17 |
| 2023-06-30 |
$17 |
| 2023-03-31 |
$20 |
| 2022-12-31 |
$17 |
| 2022-09-30 |
$19 |
| 2022-06-30 |
$23 |
| 2022-03-31 |
$16 |
| 2021-12-31 |
$17 |
| 2021-09-30 |
$11 |
| 2021-06-30 |
$18 |
| 2021-03-31 |
$15 |
| 2020-12-31 |
$18 |
| 2020-09-30 |
$18 |
| 2020-06-30 |
$16 |
| 2020-03-31 |
$15 |
| 2019-12-31 |
$20 |
| 2019-09-30 |
$19 |
| 2019-06-30 |
$16 |
| 2019-03-31 |
$15 |
| 2018-12-31 |
$17 |
| 2018-09-30 |
$11 |
| 2018-06-30 |
$15 |
| 2018-03-31 |
$14 |
| 2017-12-31 |
$11 |
| 2017-09-30 |
$10 |
| 2017-06-30 |
$11 |
| 2017-03-31 |
$11 |
| 2016-12-31 |
$13 |
| 2016-09-30 |
$10 |
| 2016-06-30 |
$11 |
| 2016-03-31 |
$9 |
| 2015-12-31 |
$9 |
| 2015-09-30 |
$11 |
| 2015-06-30 |
$11 |
| 2015-03-31 |
$7 |
| 2014-12-31 |
$8 |
| 2014-09-30 |
$9 |
| 2014-06-30 |
$6 |
| 2014-03-31 |
$6 |
| 2013-12-31 |
$7 |
| 2013-09-30 |
$9 |
| 2013-06-30 |
$8 |
| 2013-03-31 |
$9 |
| 2012-12-31 |
|
| 2012-09-30 |
|
| 2012-06-30 |
|
| 2012-03-31 |
|
| 2011-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$1.150B |
$0.732B |
|
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
|
